Market closedNon-fractional

RxSight/RXST

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About RxSight

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Ticker

RXST

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Aliso Viejo, United States

Employees

374

RxSight Metrics

BasicAdvanced
$2.2B
Market cap
-
P/E ratio
-$1.24
EPS
1.20
Beta
-
Dividend rate
$2.2B
1.2
9.197
8.015
0.554
1.538
-26.37%
-15.45%
-28.81%
20.17
12.92
12.92
-52.07
75.67%
-42.71%
87.76%
-31.55%

What the Analysts think about RxSight

Analyst Ratings

Majority rating from 8 analysts.
Buy

RxSight Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-30.84% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$30M
3.51%
Net income
-$9.1M
-0.00%
Profit margin
-30.84%
-3.38%

RxSight Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 6.10%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.40
-$0.35
-$0.26
-$0.25
-
Expected
-$0.47
-$0.43
-$0.36
-$0.27
-$0.20
Surprise
-14.89%
-19.23%
-28.21%
-6.10%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for RxSight stock?

RxSight (RXST) has a market cap of $2.2B as of July 05, 2024.

What is the P/E ratio for RxSight stock?

The price to earnings (P/E) ratio for RxSight (RXST) stock is 0 as of July 05, 2024.

Does RxSight stock pay dividends?

No, RxSight (RXST) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next RxSight dividend payment date?

RxSight (RXST) stock does not pay dividends to its shareholders.

What is the beta indicator for RxSight?

RxSight (RXST) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell RxSight stock

Buy or sell RxSight stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing